(TFX) |
| 0 (0%) 10-10 19:07 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 133.18 |
| Resistance 1: | 126.51 |
| Pivot price: | 123.71 |
| Support 1: | 115.73 |
| Support 2: | 96.29 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 4.290 |
| Book Value | 96.010 |
| PEG Ratio | 0.00 |
| Gross Profit | 38.470 |
| Profit Margin (%) | 6.31 |
| Operating Margin (%) | 24.16 |
| Return on Assets (ttm) | 5.4 |
| Return on Equity (ttm) | 4.4 |
Company news
Fri, 10 Oct 2025
How TFX stock trades after earnings - 2025 Bull vs Bear & Safe Swing Trade Setups - newser.com
Thu, 09 Oct 2025
Teleflex's (TFX) "Sell (D+)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Thu, 09 Oct 2025
Robeco Institutional Asset Management B.V. Sells 16,838 Shares of Teleflex Incorporated $TFX - MarketBeat
Wed, 08 Oct 2025
Jupiter Endovascular exceeds $40M series B fundraising target for its TFX platform - Fierce Biotech
Wed, 08 Oct 2025
Jupiter Endovascular Closes Oversubscribed Series B Financing, Surpassing $40 Million Target - BioSpace
Tue, 07 Oct 2025
Teleflex (TFX): Exploring Current Valuation After BIOTRONIK Vascular Intervention Acquisition - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
